Lexicon Pharmaceuticals, Inc.

NASDAQ (USD): Lexicon Pharmaceuticals, Inc. (LXRX)

Last Price

1.69

Today's Change

+0.08 (4.96%)

Day's Change

1.62 - 1.71

Trading Volume

2,943,608

Overview

Market Cap

610 Million

Shares Outstanding

361 Million

Avg Volume

2,896,498

Avg Price (50 Days)

1.72

Avg Price (200 Days)

1.88

PE Ratio

-2.17

EPS

-0.78

Earnings Announcement

06-Nov-2024

Previous Close

1.61

Open

1.63

Day's Range

1.62 - 1.7099

Year Range

0.92 - 3.73

Trading Volume

2,962,697

Price Change Highlight

1 Day Change

4.97%

5 Day Change

6.96%

1 Month Change

4.97%

3 Month Change

1.20%

6 Month Change

-17.96%

Ytd Change

6.29%

1 Year Change

56.48%

3 Year Change

-68.76%

5 Year Change

-52.53%

10 Year Change

-81.43%

Max Change

-98.71%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment